Skip to main content

iQor CXBPO™ Acquires OP360 to Expand Global CX Capabilities

People-First Culture and Operational Excellence Unite to Enhance Scale, Talent, and Service Innovation FT. LAUDERDALE, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) — iQor CXBPO™ (“iQor”), a global leader in customer experience business process outsourcing (“BPO”), today announced its acquisition of OP360, a high-performing BPO provider known for its people-first culture, operational excellence, and exceptional service delivery. This strategic combination strengthens iQor’s delivery of seamless, tech-enabled CX and back-office solutions while expanding global scale across key markets. Founded with a commitment to employee engagement and high-quality service, OP360 provides a wide range of customer support, back-office, sales, and technical services to global clients across diverse industries. With strong operational depth and trusted...

Continue reading

CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation

All-share acquisition positions Inspira to expand into a multi-billion dollar diagnostics market with a development-ready innovative technology; transaction structured to include significant protections for existing shareholders of Inspira relating to its existing technologies RA’ANANA, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) — Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced it has entered into a non-binding term sheet (the “Term Sheet”), outlining the principal terms of a proposed two-part transaction that would include the acquisition of an advanced liquid biopsy diagnostics business, together with a concurrent $15 million strategic equity investment into the Company, subject...

Continue reading

Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation

All-share acquisition positions Inspira to expand into a multi-billion dollar diagnostics market with a development-ready innovative technology; transaction structured to include significant protections for existing shareholders of Inspira relating to its existing technologies RA’ANANA, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) — Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced it has entered into a non-binding term sheet (the “Term Sheet”), outlining the principal terms of a proposed two-part transaction that would include the acquisition of an advanced liquid biopsy diagnostics business, together with a concurrent $15 million strategic equity investment into the Company, subject...

Continue reading

Business First Bancshares, Inc. Completes Acquisition of Progressive Bank

BATON ROUGE, La., Jan. 05, 2026 (GLOBE NEWSWIRE) — Business First Bancshares, Inc. (Nasdaq: BFST) (Business First), the holding company for b1BANK, announced today the successful completion of its previously announced acquisition of Progressive Bancorp, Inc. (Progressive) and its wholly-owned bank subsidiary, Progressive Bank. “We love this opportunity to build upon the investments we’ve made for many years in this important part of our footprint,” said Jude Melville, chairman, president and CEO of Business First. “Our teams have known each other for a long time and, given the similar cultural approaches and priorities of our respective organizations, it feels to me very much like coming home. We look forward to contributing to North Louisiana’s success by together serving clients across the region more deeply than either of us...

Continue reading

Wyld Acquires Grön in Major Industry Transaction

Two Of The Cannabis Industry’s Most Acclaimed And Successful Edibles Brands Are Joining Forces, Combining Their Market Expertise, Distribution Networks And Product Innovation Pipelines To Create The Unquestioned Leader In Cannabis Edibles PORTLAND, Ore., Jan. 05, 2026 (GLOBE NEWSWIRE) — Wyld, the most recognized and widely available cannabis edibles brand in North America, today announced the acquisition of Grön, a pioneering women-led edibles company known for its innovation, craftsmanship, and premium product portfolio. Both companies were founded in Oregon and remain proudly headquartered in the state, sharing deep roots in the market that helped shape the cannabis edible category. The transaction is expected to go into effect in Q1 2026, subject to regulatory approvals. This combination of Wyld and Grön brings together two...

Continue reading

Life360 Completes Acquisition of Nativo and Surpasses 50 Million U.S. MAU

Family connection company crosses key milestone as it begins integrating Nativo’s ad technology and premium publisher network to create the leading platform for brands to reach families SAN FRANCISCO, Jan. 05, 2026 (GLOBE NEWSWIRE) — Life360 (Nasdaq: LIF; ASX: 360), the leading family connection and safety company, today announced that it has completed the acquisition of Nativo, a leading advertising technology company, for approximately $120 million, comprised of 65% cash and 35% stock. With this acquisition, Life360 will help brands reach families with more relevant messages in more relevant places, both inside the Life360 app and across Connected TV, mobile, and premium digital environments. With more than 50 million Monthly Active Users (MAU) in the United States, Life360 represents one of the largest and most engaged first-party...

Continue reading

Gold.com Closes Monex Precious Metals Acquisition, Provides an Operational Update, and a Link to the Livestream of the January 27, 2026 Ringing of the NYSE’s Opening Bell

COSTA MESA, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) — Gold.com, Inc. (NYSE: GOLD) (“Gold.com” or the “Company”), a fully integrated alternative assets platform that offers an extensive range of precious metals, numismatic coins, and collectibles to consumers, collectors, and institutional clients worldwide, announced the following, today:Closed the acquisition of Monex Deposit Company and certain related entities (Monex) on January 2, 2026; Acquired an additional 24.5% equity interest in United Kingdom-based Atkinsons Bullion & Coins (Atkinsons), increasing its total ownership to 49.5%; and The sale by Stack’s Bowers Galleries of the final “Omega” pennies for approximately $16.8 million.Monex Transaction UpdateGold.com closed its previously announced acquisition of Monex, a leading precious metals dealer providing investors...

Continue reading

Norwood Financial Corp Completes Acquisition of PB Bankshares, Inc.

HONESDALE, Pa., Jan. 05, 2026 (GLOBE NEWSWIRE) — Norwood Financial Corp (NASDAQ Global Market: NWFL) (“Norwood”), the holding company for Wayne Bank, announced today that it had completed its acquisition of PB Bankshares, Inc. (“PB Bankshares”) and its wholly-owned subsidiary, Presence Bank effective as of January 5, 2026. Presence Bank has been merged into Wayne Bank. At their election, PB Bankshares shareholders are receiving either $19.75 in cash or 0.7850 shares of Norwood common stock for each share of PB Bankshares common stock held subject to the allocation and proration procedures set forth in the Merger Agreement. In lieu of fractional shares of Norwood common stock, PB Bankshares shareholders will receive cash at the rate of approximately $29.08 per share of Norwood common stock. PB Bankshares’ shareholders who have not...

Continue reading

Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice

Acquisition adds complementary asset to the Pelthos commercial portfolio Xeglyze is a novel, FDA-approved prescription medication indicated for the topical treatment of head lice infestation in patients 6 months of age and olderDURHAM, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced it has acquired Xeglyze® (abametapir) from Hatchtech Pty Ltd., an Australian biotech company, for $1.8 million. Xeglyze is a pediculicide indicated for the topical treatment of head lice infestation in patients 6 months of age and older. The prescription medication was approved by the U.S. Food and Drug Administration (“FDA”) in July 2020. The acquisition will provide...

Continue reading

Form 8.3 – [IDOX PLC – 02 01 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.